Guidelines For Distributors
Guidelines For Distributors
Guidelines For Distributors
To ensure that all concerned stakeholders understand the process for the
application of a license to operate and the regulatory requirements during
operations
To ensure the quality and identity of products during all aspects of the
distribution process
To set out appropriate steps to assist in fulfilling the responsibilities involved in
the difference aspects of the distribution process within the supply chain
To avoid the introduction of counterfeits into the marketplace via the
distribution chain
To ensure traceability and accountability of all products within the supply chain
COVERAGE
1. Activity
2. Location and Premise
3. Personnel
4. Quality System and Documentation
5. Products
6. Application Process
ACTIVITY
Location
Actual address must be consistent with the declared address
in the application
Premise
Business name registration must be
consistent with signboard in front of the
place of business bearing its name
Premise
Premise
ENDS/ENNDS products offered must have
necessary authorizations
Advertising
Advertising to the general public is not allowed.
General Requirements:
1. Organizational chart showing the hierarchy of responsibilities
General Manager / President
Regulatory Compliance
Admin and Sales Warehousing
Department
SOPs
Written procedures of all key activities:
Hiring and Training of Key Personnel
Ordering and Receiving of Goods
Storage and Monitoring of Inventories
Handling of Expired, Returned, Reject, Damaged, and Recalled Products
Distribution of Finished Products
Records Keeping
Handling of Complaints
Product Recall
QUALITY SYSTEM AND DOCUMENTATION
Records
Comprehensive records on all receipts and issues of products
Delivery records
Product Compliance
Compliant to the technical and labeling
requirements
FDA-registered
Authorization Letter
or
Proof of Ownership
LICENSING PROCEDURE
Requirements
Accomplished online application form for Distributors
Proof of Business Name Registration
Business Permit/Barangay Permit
FDA QPIRA (Qualified Personnel in Regulatory Affairs) Certificate for
ENDS/ENNDS
Government Issued ID of authorized person and qualified personnel
Payment (PhP 10,000.00 + LRF)
Note: A notarized commitment letter shall be submitted in lieu of the QPIRA Certificate
LICENSING PROCEDURE
2. Log-in to E-portal Account at https://eportal2.fda.gov.ph
LICENSING PROCEDURE
•I. The said establishment shall be open during its business hours under the supervision of a PRC registered professional (e.g.
Pharmacists), designated qualified personnel or authorized personnel at all times;
•II. The pharmacist/s and the other appropriate allied health professionals, upon and during employment in the establishment, is/are
not and will not in any way be connected to, employed by or engaged with any other FDA-regulated establishment;
•III. The approved and valid License to Operate shall be displayed in a conspicuous place in the establishment visible to my
customers;
•IV. The establishment will change its business name, and/or brand name in the case of products, in the event that there is a similar,
same, or confusingly similar name registered with the Food and Drug Administration, or if the FDA rules later that such name is
misleading, offensive, against the law, customs, public morals, public policy or otherwise violative of relevant rules and
regulations;
LICENSING PROCEDURE
•V. The electronic copy of the files, documents, or information submitted in relation to this application are the exact duplicate
or scanned copy of the same and, any discrepancy, prejudicial contents, false claims or misrepresentation on any of the data
therein shall be a ground for the disapproval of application, or if discovered post-approval shall be a ground for the
appropriate sanctions including the revocation of the license or, and/or the filing of the appropriate legal action against me,
the owner, its officers or the establishment whenever possible;
•VI. If applying for automatic renewal, the establishment has filed the application, and have paid the complete & appropriate
renewal fee before expiry date and in which case there are no changes or variations in the establishment since last renewal of
LTO specifically but not limited to a change of location, change of ownership, change of business name, change of qualified
person, change in warehouse site, additional supplier and product lines, change in activity, change in key personnel;
•VII. The products that my establishment manufacture, distribute and/or sell are registered or to be registered with FDA prior
to distribution or sale, and that we assume primary responsibility and/or stewardship over the product in case of liability,
adverse events, and/or other public health & safety issues;
•VIII. The establishment whether for initial, renewal or automatic renewal, is still subject to inspection by FDA’s authorized
representatives at any reasonable time and the establishment and its personnel and officers undertake to respond and
cooperate fully with the FDA as regards any subsequent post-marketing activity;
LICENSING PROCEDURE
•IX. Non-compliance with the requirements and/or failure to give notice to the FDA of the change in business address,
business name, ownership, or any other circumstances in relation to the approval of this application is a ground for the
revocation of the License to Operate;
•X. The above declarations and undertakings which are based on existing regulations are deemed conditions for the approval
of the LTO and therefore non-compliance or defiance after approval can be a cause for SUSPENSION, CANCELLATION,
REVOCATION of the License to Operate which shall be guided by the provisions of Republic Act 3720 as amended by
Republic Act 9711 and other relevant laws, rules and regulations;
•XI. This document is executed in full knowledge and awareness of Republic Act 3720, as amended by Republic Act 9711,
otherwise known as the Food and Drug Administration Act of 2009, other relevant laws and their implementing rules and
regulations; and
•XII. I and the establishment herein represented grants authority to the Food and Drug administration to verify through
government and private resources the veracity of the information provided in all submissions and the authenticity of all the
documents attached or submitted.
LICENSING PROCEDURE
9. Pay Fee